Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Eriocitrin has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Eriocitrin is eriodictyol carrying a rutinose sugar, and human intestinal enzymes cannot cleave the rhamnose bond. Colonic bacteria do the cleaving, which is why the aglycone and its phenolic metabolites appear in plasma late rather than soon after a dose. People differ substantially in how much they convert, and that difference tracks with which bacteria they carry rather than with the dose taken.
Hesperidin and eriocitrin are structurally near-identical apart from one hydroxyl position, and both depend on the same gut bacterial rhamnosidase step before absorption. Combining them raises total flavanone load through one shared bottleneck rather than adding an independent route. Citrus extracts commonly contain both, so the combination is usually already in the raw material.
Ascorbate regenerates phenoxyl radicals formed when a flavonoid quenches an oxidant, returning the flavonoid to its reduced form. Lemon delivers both compounds together, so the pairing reflects the natural matrix rather than a formulation invention. The chemistry is well described in vitro; what it amounts to in a person eating a normal diet is a separate question.
Flavonoid aglycones are glucuronidated and sulfated in the intestinal wall and liver, and the enzymes doing it are a shared and saturable resource. A large simultaneous dose of a second flavonoid can shift how much of each circulates as free rather than conjugated. The direction of that shift depends on the doses involved and is a pharmacokinetic point, not an efficacy claim.
Flavanone aglycones are poorly water-soluble, and phospholipid complexes are the conventional way to improve wetting and dispersion. The approach has been characterised for several citrus flavonoids. It is formulation engineering rather than a biological interaction.
Eriocitrin has been studied for effects on glucose handling and incretin signalling, and berberine is taken for overlapping reasons. Combining them means the glycaemic effects may add up rather than sit side by side. Anyone already on glucose-lowering medication should raise the combination with their prescriber before stacking.
Nothing specific on file for Eriocitrin. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 7 we read for Eriocitrin. The full linked list is below.
3 sources behind our Eriocitrin verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.